SPECIFICITY OF TUMOR-LOCALIZATION OF RADIOLABELED ANTI-CEA ANTIBODIES AND THEIR FRAGMENTS IN PATIENTS WITH CARCINOMA

被引：0
|
作者：
MACH, JP
CARREL, S
BUCHEGGER, F
FORNI, M
RITSCHARD, J
DONATH, A
ALBERTO, P
机构：
[1] LUDWIG INST CANC RES,CH-1066 EPALINGE,SWITZERLAND
[2] UNIV LAUSANNE,CH-1000 LAUSANNE,SWITZERLAND
来源：
ONCODEVELOPMENTAL BIOLOGY AND MEDICINE | 1981年 / 2卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：207 / 207
页数：1
相关论文
共 50 条
  • [21] IMPROVED RADIOIMMUNOLOCALIZATION OF CARCINOMAS USING FAB FRAGMENTS WITH ANTI-CEA SPECIFICITY
    LJUNGDAHLSTAHLE, E
    HARMENBERG, U
    RUDEN, U
    HAMMARSTROM, S
    STIGBRAND, T
    WAHREN, B
    [J]. TUMOUR BIOLOGY, 1986, 7 (5-6): : 353 - 360
  • [22] I-124 radiolabeled genetically engineered anti-CEA antibody fragments for tumor imaging with microPET.
    Sundaresan, G
    Yazaki, PJ
    Shively, JE
    Toyokuni, T
    Nguyen, KN
    Finn, R
    Larson, SM
    Raubitschek, AA
    Gambhir, SS
    Wu, AM
    [J]. JOURNAL OF NUCLEAR MEDICINE, 2001, 42 (05) : 153P - 153P
  • [23] ALTERED PHARMACOKINETIC AND TUMOR-LOCALIZATION PROPERTIES OF FAB' FRAGMENTS OF A MURINE MONOCLONAL ANTI-CEA ANTIBODY BY COVALENT MODIFICATION WITH LOW-MOLECULAR-WEIGHT DEXTRAN
    FAGNANI, R
    HALPERN, S
    HAGAN, M
    [J]. NUCLEAR MEDICINE COMMUNICATIONS, 1995, 16 (05) : 362 - 369
  • [24] INVIVO KINETICS OF RADIOLABELED MONOCLONAL ANTI-CEA ANTIBODIES IN ANIMAL-MODELS
    HAGAN, PL
    HALPERN, SE
    CHEN, A
    KRISHNAN, L
    FRINCKE, J
    BARTHOLOMEW, RM
    DAVID, GS
    CARLO, D
    [J]. JOURNAL OF NUCLEAR MEDICINE, 1985, 26 (12) : 1418 - 1423
  • [25] Tumor targeting with anti-CEA antibody fragments: Theory and experiment
    Schmidt, M.
    Wittrup, K. D.
    [J]. CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS, 2006, 21 (04) : 404 - 404
  • [26] MONOCLONAL ANTI-CEA ANTIBODIES
    ROGERS, GT
    RAWLINS, GA
    BAGSHAWE, KD
    [J]. BRITISH JOURNAL OF CANCER, 1981, 43 (04) : 562 - 562
  • [27] PENETRATION AND BINDING OF RADIOLABELED ANTI-CEA MONOCLONAL-ANTIBODIES AND THEIR F(AB')2 AND FAB FRAGMENTS IN HUMAN-COLON MULTICELLULAR TUMOR SPHEROIDS
    SUTHERLAND, R
    BUCHEGGER, F
    VACCA, A
    SCHREYER, M
    MACH, JP
    [J]. CANCER DRUG DELIVERY, 1985, 2 (03): : 239 - 239
  • [28] EFFECT OF DOSE ESCALATION OF A MONOCLONAL ANTI-CEA IGG ON TUMOR-LOCALIZATION AND TISSUE DISTRIBUTION IN NUDE-MICE XENOGRAFTED WITH HUMAN-COLON CARCINOMA
    ROGERS, GT
    PEDLEY, RB
    BODEN, J
    HARWOOD, PJ
    BAGSHAWE, KD
    [J]. CANCER IMMUNOLOGY IMMUNOTHERAPY, 1986, 23 (02) : 107 - 112
  • [29] Improved selection of patients for reoperation after primary surgery for medullary thyroid carcinoma (MTC) using radiolabeled anti-CEA antibodies.
    Juweid, M
    Sharkey, RM
    Swayne, LC
    Goldenberg, DM
    [J]. JOURNAL OF NUCLEAR MEDICINE, 1997, 38 (05) : 984 - 984
  • [30] A COMPARISON OF MONOCLONAL ANTI-CEA ANTIBODIES FOR LOCALIZATION AND THERAPY OF GASTROINTESTINAL MALIGNANCIES
    MACDONALD, F
    ALLUM, WH
    LIFE, P
    FIELDING, JWL
    [J]. BRITISH JOURNAL OF CANCER, 1986, 54 (01) : 187 - 188
12345